Importer of Controlled Substances; Notice of Registration, 5827-5829 [2011-2284]
Download as PDF
<![CDATA[
5827
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Notices
standards.ieee.org/about/sba/
dec2010.html.
On September 17, 2004, IEEE filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Reqister pursuant to Section 6(b) of the
Act on November 3, 2004 (69 FR 64105).
The last notification was filed with
the Department on July 22, 2010. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on September 9, 2010 (75 FR
54915).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2011–2076 Filed 2–1–11; 8:45 am]
BILLING CODE 4410–11–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to Title 21 Code of Federal
Regulations 1301.34(a), this is notice
that on November 9, 2010, Mallinckrodt
Inc., 3600 North Second Street, St.
Louis, Missouri 63147, made
application by renewal to the Drug
Enforcement Administration (DEA) for
registration as an importer of the
following basic classes of controlled
substances:
Drug
Schedule
srobinson on DSKHWCL6B1PROD with NOTICES
Phenylacetone (8501) ..................
Coca Leaves (9040) .....................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
16:00 Feb 01, 2011
II
II
II
II
Jkt 223001
Dated: January 18, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–2289 Filed 2–1–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
The company plans to import the
listed controlled substances for the
manufacture of controlled substances in
bulk for distribution to its customers.
No comments, objections, or requests
for any hearings will be accepted on any
application for registration or reregistration to import crude opium,
poppy straw, concentrate of poppy
straw or coca leaves. As explained in
the Correction to Notice of Application
pertaining to Rhodes Technologies, 72
FR 3417 (2007), comments and requests
for hearings on applications to import
narcotic raw material are not
appropriate.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances listed in schedule I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act (21 U.S.C.
952(a)(2)(B)) may, in the circumstances
VerDate Mar<15>2010
set forth in 21 U.S.C. 958(i), file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than March 4, 2011.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745), all applicants for
registration to import a basic class of
any controlled substance in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated June 17, 2010, and
published in the Federal Register on
June 28, 2010, (75 FR 36681), Research
Triangle Institute, Kenneth H. Davis, Jr.,
Hermann Building, East Institute Drive,
P.O. Box 12194, Research Triangle,
North Carolina 27709, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the following basic
classes of controlled substances:
Drug
Schedule
1-(1-Phenylcyclohexyl)pyrrolidine
(7458).
1-[1-(2Thienyl)cyclohexyl]piperidine
(7470).
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
I
I
Drug
1-[1-(2Thienyl)cyclohexyl]pyrrolidine
(7473).
1-Methyl-4-phenyl-4propionoxypiperidine (9661).
1-(2-Phenylethyl)-4-phenyl-4acetoxypiperidine (9663).
2,5-Dimethoxy-4-(n)propylthiophenethylamine
(7348).
2,5-Dimethoxy-4ethylamphetamine (7399).
2,5-Dimethoxyamphetamine
(7396).
3,4,5-Trimethoxyamphetamine
(7390).
3,4-Methylenedioxyamphetamine
(7400).
3,4Methylenedioxymethamphetamine (7405).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3-Methylfentanyl (9813) ................
3-Methylthiofentanyl (9833) ..........
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
4-Methylaminorex (cis isomer)
(1590).
4-Methoxyamphetamine (7411) ...
5-Methoxy-3,4methylenedioxyamphetamine
(7401).
5-Methoxy-N,Ndiisopropyltryptamine (7439).
Acetorphine (9319) .......................
Acetyl-alpha-methylfentanyl
(9815).
Acetyldihydrocodeine (9051) ........
Acetylmethadol (9601) .................
Allylprodine (9602) .......................
Alphacetylmethadol except levoalphacetylmethadol (9603).
Alpha-ethyltryptamine (7249) .......
Alphameprodine (9604) ................
Alphamethadol (9605) ..................
Alpha-methylfentanyl (9814) ........
Alpha-methylthiofentanyl (9832) ...
Alpha-methyltryptamine (7432) ....
Aminorex (1585) ...........................
Benzethidine (9606) .....................
Benzylmorphine (9052) ................
Betacetylmethadol (9607) ............
Beta-hydroxy-3-methylfentanyl
(9831).
Beta-hydroxyfentanyl (9830) ........
Betameprodine (9608) ..................
Betamethadol (9609) ....................
Betaprodine (9611) .......................
Bufotenine (7433) .........................
Cathinone (1235) ..........................
Clonitazene (9612) .......................
Codeine methylbromide (9070) ....
Codeine-N-Oxide (9053) ..............
Cyprenorphine (9054) ..................
Desomorphine (9055) ...................
Dextromoramide (9613) ...............
Diampromide (9615) .....................
Diethylthiambutene (9616) ...........
E:\FR\FM\02FEN1.SGM
02FEN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
5828
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Notices
srobinson on DSKHWCL6B1PROD with NOTICES
Drug
Schedule
Diethyltryptamine (7434) ..............
Difenoxin (9168) ...........................
Dihydromorphine (9145) ...............
Dimenoxadol (9617) .....................
Dimepheptanol (9618) ..................
Dimethylthiambutene (9619) ........
Dimethyltryptamine (7435) ...........
Dioxaphetyl butyrate (9621) .........
Dipipanone (9622) ........................
Drotebanol (9335) ........................
Ethylmethylthiambutene (9623) ....
Etonitazene (9624) .......................
Etorphine except HCl (9056) ........
Etoxeridine (9625) ........................
Fenethylline (1503) .......................
Furethidine (9626) ........................
Gamma
Hydroxybutyric
Acid
(2010).
Heroin (9200) ...............................
Hydromorphinol (9301) .................
Hydroxypethidine (9627) ..............
Ibogaine (7260) ............................
Ketobemidone (9628) ...................
Levomoramide (9629) ..................
Levophenacylmorphan (9631) ......
Lysergic acid diethylamide (7315)
Marihuana (7360) .........................
Mecloqualone (2572) ....................
Mescaline (7381) ..........................
Methaqualone (2565) ...................
Methcathinone (1237) ..................
Methyldesorphine (9302) ..............
Methyldihydromorphine (9304) .....
Morpheridine (9632) .....................
Morphine methylbromide (9305) ..
Morphine methylsulfonate (9306)
Morphine-N-Oxide (9307) .............
Myrophine (9308) .........................
N,N-Dimethylamphetamine (1480)
N-Benzylpiperazine (7493) ...........
N-Ethyl-3-piperidyl
benzilate
(7482).
N-Ethylamphetamine (1475) ........
N-Ethyl-l-phenylcyclohexylamine
(7455).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
Nicocodeine (9309) ......................
Nicomorphine (9312) ....................
N-Methyl-3-piperidyl
benzilate
(7484).
Noracymethadol (9633) ................
Norlevorphanol (9634) ..................
Normethadone (9635) ..................
Normorphine (9313) .....................
Norpipanone (9636) .....................
Para-Fluorofentanyl (9812) ..........
Parahexyl (7374) ..........................
Peyote (7415) ...............................
Phenadoxone (9637) ....................
Phenampromide (9638) ................
Phenomorphan (9647) .................
Phenoperidine (9641) ...................
Pholcodine (9314) ........................
Piritramide (9642) .........................
Proheptazine (9643) .....................
Properidine (9644) ........................
Propiram (9649) ...........................
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
Racemoramide (9645) ..................
Tetrahydrocannabinols (7370) .....
Thebacon (9315) ..........................
VerDate Mar<15>2010
16:00 Feb 01, 2011
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Jkt 223001
Drug
Schedule
Thiofentanyl (9835) ......................
Tilidine (9750) ...............................
Trimeperidine (9646) ....................
1-Phenylcyclohexylamine (7460)
1Piperidinocyclohexanecarbonitrile (8603).
Alfentanil (9737) ...........................
Alphaprodine (9010) .....................
Amobarbital (2125) .......................
Amphetamine (1100) ....................
Anileridine (9020) .........................
Bezitramide (9800) .......................
Carfentanil (9743) .........................
Coca Leaves (9040) .....................
Cocaine (9041) .............................
Codeine (9050) .............................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Dihydrocodeine (9120) .................
Dihydroetorphine (9334) ...............
Diphenoxylate (9170) ...................
Ethylmorphine (9190) ...................
Etorphine Hcl (9059) ....................
Fentanyl (9801) ............................
Glutethimide (2550) ......................
Hydrocodone (9193) .....................
Hydromorphone (9150) ................
Isomethadone (9226) ...................
Levo-alphacetylmethadol (9648) ..
Levomethorphan (9210) ...............
Levorphanol (9220) ......................
Lisdexamfetamine (1205) .............
Meperidine (9230) ........................
Meperidine intermediate-A (9232)
Meperidine intermediate-B (9233)
Meperidine intermediate-C (9234)
Metazocine (9240) ........................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Metopon (9260) ............................
Moramide intermediate (9802) .....
Morphine (9300) ...........................
Nabilone (7379) ............................
Opium, raw (9600) .......................
Opium extracts (9610) ..................
Opium fluid extract (9620) ............
Opium tincture (9630) ..................
Opium, granulated (9640) ............
Oxycodone (9143) ........................
Oxymorphone (9652) ...................
Pentobarbital (2270) .....................
Phenazocine (9715) .....................
Phencyclidine (7471) ....................
Phenmetrazine (1631) ..................
Phenylacetone (8501) ..................
Piminodine (9730) ........................
Powdered opium (9639) ...............
Racemethorphan (9732) ..............
Racemorphan (9733) ...................
Remifentanil (9739) ......................
Secobarbital (2315) ......................
Sufentanil (9740) ..........................
Thebaine (9333) ...........................
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to import small
quantities of the listed controlled
substances for the National Institute on
Drug Abuse (NIDA) for research
activities.
In addition to the basic classes of
controlled substances mentioned
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
previously in this Notice of Registration,
the Notice of Application (75 FR 36681),
dated June 17, 2010, and published in
the Federal Register on June 28, 2010,
also stated that the Research Triangle
Institute made application to be
registered as an importer of the
following schedule I controlled
substances:
N-[1-benzyl-4-piperidyl]-Nphenylpropanamide (benzylfentanyl) (drug
code: 9818)
N-[1-(2-thienyl)methyl-4-piperidyl]-Nphenylpropanamide (thenylfentanyl) (drug
code: 9834)
By Notice dated June 19, 2010, and
published in the Federal Register on
June 29, 2010, (75 FR 37300), the DEA
issued a rulemaking in the form of a
Final Rule to correct Title 21, Code of
Federal Regulations (CFR), specifically:
21 CFR 1308.11(g), by deleting
regulations which listed benzylfentanyl
(drug code: 9818) and thenylfentanyl
(drug code: 9834) as being temporarily
subject to schedule I controls under the
emergency scheduling provisions of the
Controlled Substances Act (CSA). DEA
determined that these compounds were
both essentially inactive, with no
evidence of abuse potential. Pursuant to
June 19th rulemaking (75 FR 37300),
effective June 29, 2010, both
benzylfentanyl (drug code: 9818) and
thenylfentanyl (drug code: 9834) were
no longer legally deemed to be
controlled substances. Thus, neither
benzylfentanyl (drug code: 9818) nor
thenylfentanyl (drug code: 9834) is
listed in this Notice of Registration
despite being originally listed in the
Notice of Application. (75 FR 36681)
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Research Triangle Institute to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Research Triangle
Institute to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
E:\FR\FM\02FEN1.SGM
02FEN1
5829
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Notices
Dated: January 18, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Dated: January 18, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–2284 Filed 2–1–11; 8:45 am]
[FR Doc. 2011–2288 Filed 2–1–11; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on May 25, 2010,
AMRI Rensselaer, Inc., 33 Riverside
Avenue, Rensselaer, New York 12144,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Drug
Schedule
srobinson on DSKHWCL6B1PROD with NOTICES
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Amphetamine (1100) ....................
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Pentobarbital (2270) .....................
Meperidine (9230) ........................
Fentanyl (9801) ............................
I
I
II
II
II
II
II
II
16:00 Feb 01, 2011
Jkt 223001
Schedule
Drug
The company plans to manufacture
bulk controlled substances for use in
product development and for
distribution to its customers.
In reference to drug code 7360
(Marihuana), the company plans to bulk
manufacture cannabidiol as a synthetic
intermediate. This controlled substance
will be further synthesized to bulk
manufacture a synthetic THC (7370). No
other activity for this drug code is
authorized for this registration.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than April 4, 2011.
VerDate Mar<15>2010
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on November 24,
2010, Sigma Aldrich Research
Biochemicals, Inc., 1–3 Strathmore
Road, Natick, Massachusetts 01760–
2447, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following classes of
controlled substances:
Cathinone (1235) ...........................
Methcathinone (1237) ....................
Aminorex (1585) .............................
Alpha-ethyltryptamine (7249) .........
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols (7370) .......
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine (7392).
2,5-Dimethoxyamphetamine (7396)
3,4-Methylenedioxyamphetamine
(7400).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (MDMA) (7405).
Psilocybin (7437) ............................
5-Methoxy-N,Ndiisopropyltryptamine (7439).
1-[1-(2Thienyl)cyclohexyl]piperidine
(TCP) (7470).
N-Benzylpiperazine (BZP) (7493) ..
Heroin (9200) .................................
Normorphine (9313) .......................
Amphetamine (1100) ......................
Methamphetamine (1105) ..............
Nabilone (7379) ..............................
1-Phenylcyclohexylamine (7460) ...
Phencyclidine (7471) ......................
Cocaine (9041) ...............................
Codeine (9050) ..............................
Diprenorphine (9058) .....................
Ecgonine (9180) .............................
Levomethorphan (9210) .................
Levorphanol (9220) ........................
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
Drug
Meperidine (9230) ..........................
Metazocine (9240) .........................
Methadone (9250) ..........................
Morphine (9300) .............................
Thebaine (9333) .............................
Levo-alphacetylmethadol (9648) ....
Remifentanil (9739) ........................
Carfentanil (9743) ..........................
Fentanyl (9801) ..............................
Schedule
II
II
II
II
II
II
II
II
II
The company plans to manufacture
reference standards.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than April 4, 2011.
Dated: January 18, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–2237 Filed 2–1–11; 8:45 am]
BILLING CODE 4410–09–P
I
DEPARTMENT OF JUSTICE
I
I
Drug Enforcement Administration
I
Manufacturer of Controlled
Substances; Notice of Registration
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
By Notice dated August 3, 2010, and
published in the Federal Register on
September 1, 2010, 75 FR 53719,
Cambridge Isotope Lab, 50 Frontage
Road, Andover, Massachusetts 01810,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of Morphine (9300), a
basic class of controlled substance listed
in schedule II.
The company plans to utilize small
quantities of the listed controlled
substance in the preparation of
analytical standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Cambridge Isotope Lab to manufacture
the listed basic class of controlled
substance is consistent with the public
interest at this time. DEA has
E:\FR\FM\02FEN1.SGM
02FEN1
]]>Agencies
[Federal Register Volume 76, Number 22 (Wednesday, February 2, 2011)]
[Notices]
[Pages 5827-5829]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-2284]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated June 17, 2010, and published in the Federal
Register on June 28, 2010, (75 FR 36681), Research Triangle Institute,
Kenneth H. Davis, Jr., Hermann Building, East Institute Drive, P.O. Box
12194, Research Triangle, North Carolina 27709, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as an importer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
1-(1-Phenylcyclohexyl)pyrrolidine (7458)... I
1-[1-(2-Thienyl)cyclohexyl]piperidine I
(7470).
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine I
(7473).
1-Methyl-4-phenyl-4-propionoxypiperidine I
(9661).
1-(2-Phenylethyl)-4-phenyl-4- I
acetoxypiperidine (9663).
2,5-Dimethoxy-4-(n)- I
propylthiophenethylamine (7348).
2,5-Dimethoxy-4-ethylamphetamine (7399).... I
2,5-Dimethoxyamphetamine (7396)............ I
3,4,5-Trimethoxyamphetamine (7390)......... I
3,4-Methylenedioxyamphetamine (7400)....... I
3,4-Methylenedioxymethamphetamine (7405)... I
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3-Methylfentanyl (9813).................... I
3-Methylthiofentanyl (9833)................ I
4-Bromo-2,5-dimethoxyamphetamine (7391).... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
4-Methyl-2,5-dimethoxyamphetamine (7395)... I
4-Methylaminorex (cis isomer) (1590)....... I
4-Methoxyamphetamine (7411)................ I
5-Methoxy-3,4-methylenedioxyamphetamine I
(7401).
5-Methoxy-N,N-diisopropyltryptamine (7439). I
Acetorphine (9319)......................... I
Acetyl-alpha-methylfentanyl (9815)......... I
Acetyldihydrocodeine (9051)................ I
Acetylmethadol (9601)...................... I
Allylprodine (9602)........................ I
Alphacetylmethadol except levo- I
alphacetylmethadol (9603).
Alpha-ethyltryptamine (7249)............... I
Alphameprodine (9604)...................... I
Alphamethadol (9605)....................... I
Alpha-methylfentanyl (9814)................ I
Alpha-methylthiofentanyl (9832)............ I
Alpha-methyltryptamine (7432).............. I
Aminorex (1585)............................ I
Benzethidine (9606)........................ I
Benzylmorphine (9052)...................... I
Betacetylmethadol (9607)................... I
Beta-hydroxy-3-methylfentanyl (9831)....... I
Beta-hydroxyfentanyl (9830)................ I
Betameprodine (9608)....................... I
Betamethadol (9609)........................ I
Betaprodine (9611)......................... I
Bufotenine (7433).......................... I
Cathinone (1235)........................... I
Clonitazene (9612)......................... I
Codeine methylbromide (9070)............... I
Codeine-N-Oxide (9053)..................... I
Cyprenorphine (9054)....................... I
Desomorphine (9055)........................ I
Dextromoramide (9613)...................... I
Diampromide (9615)......................... I
Diethylthiambutene (9616).................. I
[[Page 5828]]
Diethyltryptamine (7434)................... I
Difenoxin (9168)........................... I
Dihydromorphine (9145)..................... I
Dimenoxadol (9617)......................... I
Dimepheptanol (9618)....................... I
Dimethylthiambutene (9619)................. I
Dimethyltryptamine (7435).................. I
Dioxaphetyl butyrate (9621)................ I
Dipipanone (9622).......................... I
Drotebanol (9335).......................... I
Ethylmethylthiambutene (9623).............. I
Etonitazene (9624)......................... I
Etorphine except HCl (9056)................ I
Etoxeridine (9625)......................... I
Fenethylline (1503)........................ I
Furethidine (9626)......................... I
Gamma Hydroxybutyric Acid (2010)........... I
Heroin (9200).............................. I
Hydromorphinol (9301)...................... I
Hydroxypethidine (9627).................... I
Ibogaine (7260)............................ I
Ketobemidone (9628)........................ I
Levomoramide (9629)........................ I
Levophenacylmorphan (9631)................. I
Lysergic acid diethylamide (7315).......... I
Marihuana (7360)........................... I
Mecloqualone (2572)........................ I
Mescaline (7381)........................... I
Methaqualone (2565)........................ I
Methcathinone (1237)....................... I
Methyldesorphine (9302).................... I
Methyldihydromorphine (9304)............... I
Morpheridine (9632)........................ I
Morphine methylbromide (9305).............. I
Morphine methylsulfonate (9306)............ I
Morphine-N-Oxide (9307).................... I
Myrophine (9308)........................... I
N,N-Dimethylamphetamine (1480)............. I
N-Benzylpiperazine (7493).................. I
N-Ethyl-3-piperidyl benzilate (7482)....... I
N-Ethylamphetamine (1475).................. I
N-Ethyl-l-phenylcyclohexylamine (7455)..... I
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
Nicocodeine (9309)......................... I
Nicomorphine (9312)........................ I
N-Methyl-3-piperidyl benzilate (7484)...... I
Noracymethadol (9633)...................... I
Norlevorphanol (9634)...................... I
Normethadone (9635)........................ I
Normorphine (9313)......................... I
Norpipanone (9636)......................... I
Para-Fluorofentanyl (9812)................. I
Parahexyl (7374)........................... I
Peyote (7415).............................. I
Phenadoxone (9637)......................... I
Phenampromide (9638)....................... I
Phenomorphan (9647)........................ I
Phenoperidine (9641)....................... I
Pholcodine (9314).......................... I
Piritramide (9642)......................... I
Proheptazine (9643)........................ I
Properidine (9644)......................... I
Propiram (9649)............................ I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
Racemoramide (9645)........................ I
Tetrahydrocannabinols (7370)............... I
Thebacon (9315)............................ I
Thiofentanyl (9835)........................ I
Tilidine (9750)............................ I
Trimeperidine (9646)....................... I
1-Phenylcyclohexylamine (7460)............. II
1-Piperidinocyclohexanecarbonitrile (8603). II
Alfentanil (9737).......................... II
Alphaprodine (9010)........................ II
Amobarbital (2125)......................... II
Amphetamine (1100)......................... II
Anileridine (9020)......................... II
Bezitramide (9800)......................... II
Carfentanil (9743)......................... II
Coca Leaves (9040)......................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Dihydrocodeine (9120)...................... II
Dihydroetorphine (9334).................... II
Diphenoxylate (9170)....................... II
Ethylmorphine (9190)....................... II
Etorphine Hcl (9059)....................... II
Fentanyl (9801)............................ II
Glutethimide (2550)........................ II
Hydrocodone (9193)......................... II
Hydromorphone (9150)....................... II
Isomethadone (9226)........................ II
Levo-alphacetylmethadol (9648)............. II
Levomethorphan (9210)...................... II
Levorphanol (9220)......................... II
Lisdexamfetamine (1205).................... II
Meperidine (9230).......................... II
Meperidine intermediate-A (9232)........... II
Meperidine intermediate-B (9233)........... II
Meperidine intermediate-C (9234)........... II
Metazocine (9240).......................... II
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
Methamphetamine (1105)..................... II
Methylphenidate (1724)..................... II
Metopon (9260)............................. II
Moramide intermediate (9802)............... II
Morphine (9300)............................ II
Nabilone (7379)............................ II
Opium, raw (9600).......................... II
Opium extracts (9610)...................... II
Opium fluid extract (9620)................. II
Opium tincture (9630)...................... II
Opium, granulated (9640)................... II
Oxycodone (9143)........................... II
Oxymorphone (9652)......................... II
Pentobarbital (2270)....................... II
Phenazocine (9715)......................... II
Phencyclidine (7471)....................... II
Phenmetrazine (1631)....................... II
Phenylacetone (8501)....................... II
Piminodine (9730).......................... II
Powdered opium (9639)...................... II
Racemethorphan (9732)...................... II
Racemorphan (9733)......................... II
Remifentanil (9739)........................ II
Secobarbital (2315)........................ II
Sufentanil (9740).......................... II
Thebaine (9333)............................ II
------------------------------------------------------------------------
The company plans to import small quantities of the listed
controlled substances for the National Institute on Drug Abuse (NIDA)
for research activities.
In addition to the basic classes of controlled substances mentioned
previously in this Notice of Registration, the Notice of Application
(75 FR 36681), dated June 17, 2010, and published in the Federal
Register on June 28, 2010, also stated that the Research Triangle
Institute made application to be registered as an importer of the
following schedule I controlled substances:
N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl) (drug
code: 9818)
N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
(thenylfentanyl) (drug code: 9834)
By Notice dated June 19, 2010, and published in the Federal
Register on June 29, 2010, (75 FR 37300), the DEA issued a rulemaking
in the form of a Final Rule to correct Title 21, Code of Federal
Regulations (CFR), specifically: 21 CFR 1308.11(g), by deleting
regulations which listed benzylfentanyl (drug code: 9818) and
thenylfentanyl (drug code: 9834) as being temporarily subject to
schedule I controls under the emergency scheduling provisions of the
Controlled Substances Act (CSA). DEA determined that these compounds
were both essentially inactive, with no evidence of abuse potential.
Pursuant to June 19th rulemaking (75 FR 37300), effective June 29,
2010, both benzylfentanyl (drug code: 9818) and thenylfentanyl (drug
code: 9834) were no longer legally deemed to be controlled substances.
Thus, neither benzylfentanyl (drug code: 9818) nor thenylfentanyl (drug
code: 9834) is listed in this Notice of Registration despite being
originally listed in the Notice of Application. (75 FR 36681)
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Research Triangle Institute to import the basic classes
of controlled substances is consistent with the public interest and
with United States obligations under international treaties,
conventions, or protocols in effect on May 1, 1971. DEA has
investigated Research Triangle Institute to ensure that the company's
registration is consistent with the public interest. The investigation
has included inspection and testing of the company's physical security
systems, verification of the company's compliance with state and local
laws, and a review of the company's background and history. Therefore,
pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR
1301.34, the above named company is granted registration as an importer
of the basic classes of controlled substances listed.
[[Page 5829]]
Dated: January 18, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-2284 Filed 2-1-11; 8:45 am]
BILLING CODE 4410-09-P
